RITA Medical Systems to Present at UBS Global Life Sciences Conference MOUNTAIN VIEW, Calif., Sept. 23 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) today announced that President and CEO Joseph M. DeVivo is scheduled to make an investor presentation at the UBS Global Life

RITA Medical Systems Announces Radiofrequency Ablation Liver Treatment Coverage Initiated by CIGNA HealthCare MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Sept. 14, 2004-- August 2004 Coverage Position Published for Unresectable Primary and Metastatic Liver Cancer RITA Medical Systems, Inc.

Darrin Uecker, CTO, Assumes Operations Responsibilities, Trent Reutiman Named Vice President, Sales and Marketing

AngioDynamics to Rename Laser Venous System QUEENSBURY, N.Y.--(BUSINESS WIRE)--Aug. 5, 2004--AngioDynamics, Inc., (Nasdaq:ANGO) today announced that it is changing the name of its endovascular laser venous system to VenaCure ™ Laser Vein Treatment.

RITA Medical Systems Announces Second Quarter, Six-Month Results Record Domestic Sales Growth Achieved and System Utilization Up 15 Percent Year-over-Year for First Six Months of 2004 Merger Completed - Combination of RITA and Horizon Expected to Create Profitable Medical Oncology Device Company

RITA Medical Systems Completes Merger With Horizon Medical Products MOUNTAIN VIEW, Calif., Jul 30, 2004 /PRNewswire-FirstCall via COMTEX/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) today announced that it completed its merger with Horizon Medical Products, Inc. effective on July 29, 2004.

AngioDynamics Fiscal 2004 Fourth Quarter Net Earnings Nearly Triple on 26% Growth in Net Sales; Conference Call to Begin at 4:30 P.M. EDT Today QUEENSBURY, N.Y.--(BUSINESS WIRE)--July 29, 2004--AngioDynamics, Inc. (Nasdaq:ANGO) today announced financial results for the three and 12 months ended May

AngioDynamics Receives 510-k- Clearance of MORPHEUS CT PICC QUEENSBURY, N.Y.--(BUSINESS WIRE)--July 28, 2004--AngioDynamics, Inc. (Nasdaq:ANGO), today announces 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the MORPHEUS ™ CT PICC.

AngioDynamics to Present at Adams Harkness' 24th Annual Summer Seminar on August 3, 2004 QUEENSBURY, N.Y.--(BUSINESS WIRE)--July 27, 2004--AngioDynamics, Inc. (Nasdaq:ANGO) today announced that management will present at the Adams Harkness 24th Annual Summer Seminar on Tuesday August 3, 2004 at

AngioDynamics to Hold Fiscal Fourth Quarter and 2004 Financial Results Conference Call on Thursday, July 29, 2004 QUEENSBURY, N.Y.--(BUSINESS WIRE)--July 22, 2004--AngioDynamics, Inc. (Nasdaq:ANGO) today announced that the company will release fourth quarter and 2004 year end results on Thursday,

AngioDynamics Announces Exercise of Over-Allotment Option QUEENSBURY, N.Y.--(BUSINESS WIRE)--July 14, 2004--AngioDynamics, Inc., (Nasdaq:ANGO) today announced that the underwriters of its initial public offering of May 27, 2004 have exercised their over-allotment option in full to purchase an

RITA Medical Systems Announces Second Quarter, Six-Month Results Release and Conference Call Date MOUNTAIN VIEW, Calif., Jul 8, 2004 /PRNewswire-FirstCall via COMTEX/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) today announced plans to release its financial results for the second quarter and six

Merger With Horizon Medical Products Expected to Close Same Day
Pending Stockholder Approval Vote

AngioDynamics Announces the Release of the Dynamic Flow Chronic Hemodialysis Catheter QUEENSBURY, N.Y.--(BUSINESS WIRE)--June 17, 2004--AngioDynamics, Inc., (Nasdaq:ANGO) today announced its release of the Dynamic Flow ™ chronic hemodialysis catheter.

92% Survival Rate in Stage I Non-Small Cell Lung Cancer Patients at One Year Reported Using Rita Medical Systems Products MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--June 8, 2004-- 14 Patients Treated With Percutaneous Radiofrequency Ablation as Sole Anti-Cancer Treatment in International Multicenter

RITA Medical Systems To Present at the Pacific Growth Equities Life Sciences Growth Conference MOUNTAIN VIEW, Calif., Jun 4, 2004 (BUSINESS WIRE) -- RITA Medical Systems, Inc. (Nasdaq: RITA) today announced that it is scheduled to make an investor presentation at the Pacific Growth Equities Life

RITA Medical Systems to Provide Educational Grant to Support Continuing Medical Education Program MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--June 3, 2004-- Continuing Medical Education Program on Medscape Internet Site to Inform Medical Oncologists and Interventional Radiologists about Radiofrequency

AngioDynamics Announces Pricing of Public Offering QUEENSBURY, N.Y.--(BUSINESS WIRE)--May 27, 2004--AngioDynamics, Inc. (Nasdaq:ANGO), a subsidiary of E-Z-EM, Inc. (AMEX:EZM), today announced its public offering of 1,950,000 shares of common stock at a price of $11.00 per share.

RITA Medical Systems and Horizon Medical Products Announce Merger Agreement Merger Expected to Result in Profitable Medical Oncology Device Company MOUNTAIN VIEW, Calif. and ATLANTA, Ga., May 13 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. ("RITA") (Nasdaq: RITA) and Horizon Medical

AngioDynamics Announces Availability of Mariner™ Hydrophilic Angiographic Catheter Queensbury, NY, May 12, 2004 – ANGIODYNAMICS, INC., a wholly owned subsidiary of E-Z-EM, Inc., (AMEX: EZM) today announced the release of the Mariner™ angiographic catheter, a